FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system

OBJECTIVE: Available chemotherapy presents poor control over the development of metastatic melanoma. FTY720 is a compound already approved by the Food and Drug Administration for the treatment of patients with multiple sclerosis. It has also been observed that FTY720 inhibits tumor growth in vivo (e...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Felipe V., Arruda, Denise C., Figueiredo, Carlos R., Massaoka, Mariana H., Matsuo, Alisson L., Bueno, Valquiria, Rodrigues, Elaine G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Materias:
Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715017/
https://www.ncbi.nlm.nih.gov/pubmed/23917669
http://dx.doi.org/10.6061/clinics/2013(07)21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715017/
https://www.ncbi.nlm.nih.gov/pubmed/23917669
http://dx.doi.org/10.6061/clinics/2013(07)21

Ejemplares similares